Clinical Trial Update: Prior Axitinib as a Determinant of Outcome of Renal Surgery [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating whether prior axitinib affects surgical outcomes in clear cell renal cell carcinoma; the study is currently active but not rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clear Cell Renal Cell Carcinoma

Drugs mentioned

• Inlyta (Axitinib) (Axitinib)

Snippet

Sponsor: University of California, San Diego | Conditions: Clear Cell Renal Cell Carcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING